Royal Bank of Canada Lowers SOPHiA GENETICS (NASDAQ:SOPH) Price Target to $7.00
SOPHiA GENETICS (NASDAQ:SOPH – Get Free Report) had its price target dropped by research analysts at Royal Bank of Canada from $8.00 to $7.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target indicates a potential upside of 102.31% from […]
More Stories
Mereo BioPharma Group’s (MREO) “Buy” Rating Reiterated at Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a...
Rockingstone Advisors LLC Makes New Investment in Natera, Inc. (NASDAQ:NTRA)
Rockingstone Advisors LLC bought a new position in shares of Natera, Inc. (NASDAQ:NTRA – Free Report) during the fourth quarter,...
Humacyte’s (HUMA) Buy Rating Reiterated at D. Boral Capital
D. Boral Capital restated their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note released...
Rockingstone Advisors LLC Buys New Stake in iShares Core S&P Small-Cap ETF (NYSEARCA:IJR)
Rockingstone Advisors LLC purchased a new position in shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) in...
Fifth Third Wealth Advisors LLC Acquires 1,553 Shares of 3M (NYSE:MMM)
Fifth Third Wealth Advisors LLC lifted its holdings in shares of 3M (NYSE:MMM – Free Report) by 21.5% in the...
Allen Mooney & Barnes Investment Advisors LLC Cuts Stock Position in Costco Wholesale Co. (NASDAQ:COST)
Allen Mooney & Barnes Investment Advisors LLC decreased its holdings in shares of Costco Wholesale Co. (NASDAQ:COST – Free Report)...